Björn Holzhauer

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial

Sherif Gonem, Rachid Berair, Amisha Singapuri et al. · The Lancet Respiratory Medicine · 2016 · 247 citations · Full text

Usefulness of Heart Rate to Predict Cardiac Events in Treated Patients With High-Risk Systemic Hypertension

Stevo Julius, Paolo Palatini, Sverre E. Kjeldsen et al. · The American Journal of Cardiology · 2011 · 176 citations · Full text

Hypertension, Heart Rate, Blood Pressure +12

Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

Giuseppe Mancia, Sverre E. Kjeldsen, Dion Zappe et al. · European Heart Journal · 2015 · 111 citations · Full text

Fevipiprant, an oral prostaglandin DP₂receptor (CRTh2) antagonist, in allergic asthma uncontrolled on low-dose inhaled corticosteroids

Eric D. Bateman, Alfredo G. Guerreros, Florian Brockhaus et al. · European Respiratory Journal · 2017 · 102 citations · Full text

No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

Sverre E. Kjeldsen, Eivind Berge, Sripal Bangalore et al. · Blood Pressure · 2015 · 74 citations